Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| FORMFACTOR INC | 57,610 | reported | 07 Aug 2025 | tx 119+645,676−544,796 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Aug 2025 | TAX_WITHHOLDING | FORMFACTOR INC | 1,642 | 27.98 USD | |
| 07 Aug 2025 | EXERCISE | FORMFACTOR INC | 2,955 | — | |
| 07 Aug 2025 | EXERCISE | FORMFACTOR INC | 2,955 | 0.00 USD | deriv |
| 05 Aug 2025 | EXERCISE | FORMFACTOR INC | 1,116 | — | |
| 05 Aug 2025 | TAX_WITHHOLDING | FORMFACTOR INC | 620 | 29.14 USD | |
| 05 Aug 2025 | EXERCISE | FORMFACTOR INC | 1,116 | 0.00 USD | deriv |
| 01 Aug 2025 | TAX_WITHHOLDING | FORMFACTOR INC | 2,805 | 28.93 USD | |
| 01 Aug 2025 | TAX_WITHHOLDING | FORMFACTOR INC | 9,709 | 28.93 USD | |
| 01 Aug 2025 | EXERCISE | FORMFACTOR INC | 17,477 | 0.00 USD | |
| 01 Aug 2025 | EXERCISE | FORMFACTOR INC | 5,049 | 0.00 USD | |
| 01 Aug 2025 | EXERCISE | FORMFACTOR INC | 5,049 | 0.00 USD | deriv |
| 01 Aug 2025 | EXERCISE | FORMFACTOR INC | 17,477 | 0.00 USD | deriv |
| 01 Aug 2025 | GRANT_AWARD | FORMFACTOR INC | 17,477 | 0.00 USD | deriv |
| 07 May 2025 | TAX_WITHHOLDING | FORMFACTOR INC | 1,642 | 29.66 USD | |
| 07 May 2025 | EXERCISE | FORMFACTOR INC | 2,955 | — | |
| 07 May 2025 | EXERCISE | FORMFACTOR INC | 2,955 | 0.00 USD | deriv |
| 05 May 2025 | TAX_WITHHOLDING | FORMFACTOR INC | 620 | 29.81 USD | |
| 05 May 2025 | EXERCISE | FORMFACTOR INC | 1,116 | — | |
| 05 May 2025 | EXERCISE | FORMFACTOR INC | 1,116 | 0.00 USD | deriv |
| 07 Feb 2025 | TAX_WITHHOLDING | FORMFACTOR INC | 1,751 | 35.84 USD | |
| 07 Feb 2025 | EXERCISE | FORMFACTOR INC | 2,955 | 0.00 USD | |
| 07 Feb 2025 | EXERCISE | FORMFACTOR INC | 0 | 0.00 USD | deriv |
| 05 Feb 2025 | EXERCISE | FORMFACTOR INC | 1,116 | 0.00 USD | |
| 05 Feb 2025 | TAX_WITHHOLDING | FORMFACTOR INC | 680 | 41.12 USD | |
| 05 Feb 2025 | EXERCISE | FORMFACTOR INC | 1,116 | 0.00 USD | deriv |